Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ZEAL

Zealand Pharma AS (ZEAL)

Zealand Pharma AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZEAL
DateTimeSourceHeadlineSymbolCompany
11/11/202201:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Nine Months of 2022NASDAQ:ZEALZealand Pharma AS
09/11/202200:30GlobeNewswire Inc.Zealand Pharma to Participate in Upcoming Investor ConferencesNASDAQ:ZEALZealand Pharma AS
03/11/202219:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
02/11/202203:00GlobeNewswire Inc.Zealand Pharma Announces Presentations at The Obesity Society Annual MeetingNASDAQ:ZEALZealand Pharma AS
12/10/202202:05GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Polar CapitalNASDAQ:ZEALZealand Pharma AS
11/10/202202:12GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Van Herk InvestmentsNASDAQ:ZEALZealand Pharma AS
07/10/202217:41GlobeNewswire Inc.Zealand Pharma completes registration of capital increaseNASDAQ:ZEALZealand Pharma AS
05/10/202207:07GlobeNewswire Inc.Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 millionNASDAQ:ZEALZealand Pharma AS
05/10/202202:05GlobeNewswire Inc.Zealand Pharma announces directed issue and private placement of approximately 4.5m new sharesNASDAQ:ZEALZealand Pharma AS
01/10/202206:15TipRanksNeedham Sticks to Their Buy Rating for Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
01/10/202206:00GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at September 30, 2022NASDAQ:ZEALZealand Pharma AS
30/09/202221:41TipRanksZealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive ResultsNASDAQ:ZEALZealand Pharma AS
30/09/202220:15GlobeNewswire Inc.Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)NASDAQ:ZEALZealand Pharma AS
21/09/202222:15GlobeNewswire Inc.Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)NASDAQ:ZEALZealand Pharma AS
19/09/202216:00GlobeNewswire Inc.Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE MeetingNASDAQ:ZEALZealand Pharma AS
14/09/202220:11TipRanksAnalysts’ Top Healthcare Picks: Zealand Pharma (ZEAL), POINT Biopharma Global (PNT)NASDAQ:ZEALZealand Pharma AS
14/09/202206:05GlobeNewswire Inc.Zealand Pharma grants warrants to employees in DenmarkNASDAQ:ZEALZealand Pharma AS
09/09/202206:05GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
08/09/202201:00GlobeNewswire Inc.Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:ZEALZealand Pharma AS
07/09/202216:00GlobeNewswire Inc.Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)NASDAQ:ZEALZealand Pharma AS
01/09/202205:30GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at August 31, 2022NASDAQ:ZEALZealand Pharma AS
24/08/202218:30GlobeNewswire Inc.Zealand Pharma Appoints Henriette Wennicke as Chief Financial OfficerNASDAQ:ZEALZealand Pharma AS
19/08/202204:58GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
12/08/202203:30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
11/08/202223:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Half of 2022NASDAQ:ZEALZealand Pharma AS
09/08/202206:30GlobeNewswire Inc.Updated notice to holders of ADSs regarding termination of Deposit AgreementNASDAQ:ZEALZealand Pharma AS
09/08/202206:05GlobeNewswire Inc.Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select MarketNASDAQ:ZEALZealand Pharma AS
04/08/202223:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
14/07/202220:45TipRanksZealand Pharma (ZEAL) Receives a Buy from NeedhamNASDAQ:ZEALZealand Pharma AS
30/06/202223:44GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at June 30, 2022NASDAQ:ZEALZealand Pharma AS
 Showing the most relevant articles for your search:NASDAQ:ZEAL